I agree with you completely that the lack of Kevetrin trial news is due to requests from DF but the lack all other non-trial news is seemingly based on other requirements and ongoing negotiations of some type would certainly be at the top of the list, and it is a very short list, as I can think of nothing else that would cause such a total lack of news.

My prior note of thinking we don't get quite as much news out of ASCO as  previously thought is due to cohort 4 not having started yet.  I thought by ASCO we would have easily been done with cohort 4 and that would have garnered much more data than earlier cohorts.  I still think it bodes extremely well for the trial since Dr Shapiro is the presenter.